Cocrystal or salt: Does it really matter?

Molecular Pharmaceutics

Volumn 4, Issue 3, 2007, Pages 317-322

  Aakeröy, Christer B ^a   Fasulo, Meg E ^a   Desper, John ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cocrystal; Crystal lattice; Crystal prediction; Hydrogen bonding; Salt

Indexed keywords

ANION; BENZIMIDAZOLE; BENZYL THIOCYANATE; CARBOXYLIC ACID; CARBOXYLIC ACID DERIVATIVE; PYRIDINIUM DERIVATIVE; SODIUM CHLORIDE;

ARTICLE; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTON TRANSPORT; STOICHIOMETRY; SYNTHESIS;

CARBOXYLIC ACIDS; CRYSTALLIZATION; HETEROCYCLIC COMPOUNDS; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SALTS;

EID: 34250863849     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp060126o     Document Type: Article

References (38)

1. (a) Stahl, P. H.; Nakano, M. Pharmaceutical Aspects of the Drug Salt Form. In Handbook of Pharmaceutical Salts: Properties, Selection, and Use; Stahl, P. H., Wermuth, C. G., Eds.; Wiley-VCH: New York, 2002.
2. (b) Berge, S. M.; Bighley, L. D.; Monkhouse, D. C. Pharmaceutical salts. J. Pharm. Sci. 1977, 66, 1-19.
3. Aakeröy, C. B.; Desper, J.; Urbina, J. F. Supramolecular reagents: versatile tools for non-covalent synthesis. ChemComm, 2005, 2820.
4. Pansanel, J.; Jouaiti, A.; Ferlay, S.; Hosseini, M. W.; Planeix, J.; Kyritsakas, N. Molecular tectonics: generation of 1-and 2-D copper coordination networks by positional isomeric tectons based on a phenylenediamine backbone bearing two isonicotinoyl moieties. New J. Chem. 2006, 30, 683.
5. Wuest, J. D. Engineering crystals by the strategy of molecular tectonics. Chem. Commun. 2005, 5830.
6. Almarsson, Ö.; Zaworotko, M. J. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Chem. Commun. 2004, 1889.
7. Vishweshwar, P.; McMahon, J. A.; Bis, J. A.; Zaworotko, M. J. Pharmaceutical co-crystals. J. Pharm. Sci. 2006, 95, 499.
8. Remenar, J. F.; Morissette, S. L.; Peterson, M. L.; Moulton, B.; MacPhee, J. M.; Guzman, H. R.; Almarsson, Ö. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. J. Am. Chem. Soc. 2003, 125, 8456.
9. Basavoju, S.; Bostroem, D.; Velaga, S. P. Pharmaceutical cocrystal and salts of norfloxacin. Cryst. Growth Des. 2006, 6, 2699.
10. Trask, A. V.; Motherwell, S. W. D.; Jones, W. Physical stability enhancement of theophylline via cocrystallization. Int. J. Pharm. 2006, 320, 114.
11. Reddy, S. L; Babu, J. N.; Nangia, A. Carboxamide-pyridine N-oxide heterosynthon for crystal engineering and pharmaceutical cocrystals. Chem. Commun. 2006, 1369.
12. McNamara, D. P.; Childs, S. L.; Giordano, J.; Iarriccio, A.; Cassidy, J.; Shet, M. S.; Mannion, R.; O'Donnell, E.; Park, A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm. Res. 2006, 23, 1888.
13. Aakeröy, C. B.; Salmon, D. J. Building co-crystals with molecular sense and supramolecular sensibility. CrystEngComm 2005, 7, 439.
14. Bhogala, B. R.; Basavoju, S.; Nangia, A. Three-Component Carboxylic Acid-Bipyridine Lattice Inclusion Host. Supramolecular Synthesis of Ternary Cocrystals. Cryst. Growth Des. 2005, 5, 1683.
15. Trask, A. V.; van de Streek, J.; Motherwell, S. W. D.; Jones, W. Achieving Polymorphic and Stoichiometric Diversity in Cocrystal Formation: Importance of Solid-State Grinding, Powder X-ray Structure Determination, and Seeding. Cryst. Growth. Des. 2005, 6, 2233.
16. Saha, B. K.; Nangia, A.; Jaskolski, M. Crystal engineering with hydrogen bonds and halogen bonds. CrystEngComm. 2005, 7, 355.
17. Vishweshwar, P.; McMahon, J. A.; Peterson, M. L.; Hickey, M. B.; Shattock, T. R.; Zaworotko, M. J. Crystal engineering of pharmaceutical cocrystals from polymorphic active pharmaceutical ingredients. Chem. Commun. 2005, 4601.
18. Hosseini, M. W. Reflection on molecular tectonics. CrystEngComm 2004, 6, 318.
19. Desiraju, G. R. Hydrogen Bridges in Crystal Engineering: Interactions without Borders. Acc. Chem. Res. 2002, 35, 565.
20. Shattock, T. R.; Vishweshwar, P.; Wang, Z.; Zaworotko, M. J. 8-Fold Interpenetration and Concomitant Polymorphism in the 2:3 CoCrystal of Trimesic Acid and 1,2-Bis(4-pyridyl)ethane. Cryst. Growth. Des. 2005, 6, 2046.
21. Aakeröy, C. B.; Desper, J.; Salmon, D. J.; Smith, M. M. Cyanophenyloximes: Reliable and Versatile Tools for Hydrogen-Bond Directed Supramolecular Synthesis of Cocrystals. Cryst. Growth Des. 2006, 4, 1033.
22. Aakeröy, C. B.; Fasulo, M. E.; Desper, J. Improving success rate of hydrogen-bond driven synthesis of co-crystals, CrystEngComm. 2006, 8, 586.
23. This requirement may be deemed overly restrictive, but it does offer an important distinction between solvates and cocrystals. However, in some cases, notably in the elegant work by Boese and co-workers, using low-temperature crystallizations, they intentionally prepare cocrystals with a very clear focus and deliberate strategy (see, e.g.: Kirchner, M. T.; Boese, R.; Gehrke, A.; Blaeser, D. Co-crystallization with acetylene. Part III. Molecular complexes with aromatic azacycles. CrystEngComm 2004, 6, 360).
24. Aakeröy, C. B.; Desper, J.; Scott, B. M. T. Balancing supramolecular reagents for reliable formation of co-crystals. Chem. Comm. 2006, 1445.
25. Aakeroy, C. B.; Desper, J.; Helfrich, B. A. Heteromeric intermolecular interactions as synthetic tools for the formation of binary co-crystals. CrystEngComm 2004, 6, 19.
26. Aakeröy, C. B.; Desper, J.; Leonard, B.; Urbina, J. F. Toward High-Yielding Supramolecular Synthesis: Directed Assembly of Ditopic Imidazoles/Benzimidazoles and Dicarboxylic Acids into Cocrystals via Selective O-H...N Hydrogen Bonds. CrystEngComm 2005, 5, 865.
27. Banerjee, R.; Bhatt, P. M.; Ravindra, N. V.; Desiraju, G. M. Saccharin Salts of Active Pharmaceutical Ingredients, Their Crystal Structures, and Increased Water Solubilities. Cryst. Growth Des. 2005, 6, 2299.
28. Only crystal structures of organic compounds that were successfully solved and refined were included, and all such structures obtained for a specific time period were included in the analysis in an attempt to ensure that no bias was introduced in the selection process.
29. Jerzykiewicz, L. B.; Malarski, Z.; Sobczyk, L.; Lis, T.; Grech, E. The quasi-symmetric OHN and ODN bridges in the adducts of 3,5-dimethylpyridine with 3,5-dinitrobenzoic acid. J. Mol. Struct. 1998, 440, 175.
30. Majerz, I.; Malarski, Z.; Sobczyk, L. Proton transfer and correlations between the C-O, O-H, N-H and O..N bond lengths in amine phenolates. Chem. Phys. Lett. 1997, 274, 361.
31. Cowan, J. A.; Howard, K.; McIntyre, G. J.; Lo, S. M. F.; Williams, I. D. Variable-temperature neutron diffraction studies of the short, strong N...O hydrogen bonds in the 1:2 co-crystal of benzene-1,2,4,5-tetracarboxylic acid and 4,4′-bipyridyl. Acta Crystallogr. 2003, B59, 794.
32. 2 = 0.1276 (GOF = 0.920).
33. 2 = 0.1056 (GOF = 1.050).
34. 2 = 0.1240 (GOF = 0.947).
35. 2 = 0.1240 (GOF = 1.024).
36. Wiechert, D.; Mootz, D. Molecular beside ionic: crystal structures of a 1/1 and a 1/4 adduct of pyridine and formic acid. Angew. Chem., Int. Ed. 1999, 38, 1974.
37. Nygren, C. L.; Wilson, C. C.; Turner, J. F. C. Electron and Nuclear Positions in the Short Hydrogen Bond in Urotropine-N-oxide Formic Acid. J. Phys. Chem. A 2005, 109, 1911.
38. Allen, F. A.; The Cambridge Structural Database: a quarter of a million crystal structures and rising, Acta Crystallogr. B 2002, 58, 380.